XML 61 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Capital Structure (Details) - USD ($)
1 Months Ended 3 Months Ended
Sep. 30, 2018
Jun. 30, 2016
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Capital Structure (Details) [Line Items]          
preferred shares sold per share (in Dollars per share)     $ 1,000    
Stated value, percentage     11.25%    
Common stock, shares authorized     40,000,000   40,000,000
Common stock, par value (in Dollars per share)     $ 0.0001   $ 0.0001
Issuance of warrants (in Dollars)     $ 131,250  
Warrants convertible into common stock     116,903    
Warrant [Member]          
Capital Structure (Details) [Line Items]          
Warrants exercisable for shares of common stock 5,750,000   1,055,184    
Warrant exercise price (in Dollars per share) $ 1.25   $ 1.25    
Description of warrants expiration The warrants were immediately exercisable and expire five years from the date of issuance.   The warrants are exercisable at $1.25 per share of common stock and expire on September 28, 2023.    
Issuance of warrants (in Dollars)     $ 40,000    
Valuation Expenses (in Dollars)     $ 212,923    
weighted average valuation (in Dollars per share)     $ 1.77    
Preferred Stock [Member]          
Capital Structure (Details) [Line Items]          
Preferred stock, shares authorized     500,000    
Preferred stock, par value (in Dollars per share)     $ 0.001    
Common Stock [Member]          
Capital Structure (Details) [Line Items]          
Common stock price (in Dollars per share)     $ 23.00    
Convertible preferred stock, terms of conversion, description     The Company is authorized to issue 40,000,000 shares of common stock, par value $0.0001 per share. Each share of common stock entitles the holder to one vote at all stockholder meetings.    
Common stock, shares authorized     40,000,000    
Common stock, par value (in Dollars per share)     $ 0.0001    
Consultant [Member]          
Capital Structure (Details) [Line Items]          
Warrant exercise price (in Dollars per share)     $ 1.60    
Warrants expiration period     4 years    
Consultant [Member] | Warrant [Member]          
Capital Structure (Details) [Line Items]          
Warrant exercise price (in Dollars per share)     $ 1.25    
Description of warrants expiration     The warrants are immediately exercisable and expire following the close of business on June 30, 2023.    
Warrant, description     if the closing share price on the last day of the month exceeds $1.25, then such exercise price will be 110% of the closing share price.    
Series One Convertible Preferred Stock [Member]          
Capital Structure (Details) [Line Items]          
Preferred stock conversion basis, description     each share of Series 1 Convertible Preferred Stock was convertible into 1.32230 shares of the Company’s common stock, subject to certain anti-dilution rights.    
Convertible preferred stock, terms of conversion, description     there were 170,332 shares of Series 1 Convertible Preferred Stock outstanding, which are convertible into 225,231 shares of common stock.    
Series One Convertible Preferred Stock [Member] | Preferred Stock [Member]          
Capital Structure (Details) [Line Items]          
Preferred stock, shares authorized     250,000    
Series 2 Convertible Preferred Stock [Member]          
Capital Structure (Details) [Line Items]          
Preferred stock, designated     25,000    
Convertible preferred stock, shares issued upon conversion     20,000    
Proceeds from sale of stock (in Dollars)     $ 20,000,000    
Additional sale of shares     1,952    
Gross proceeds (in Dollars)     $ 1,950,000    
Stated value, percentage     10.00%    
Cumulative accrued dividends (in Dollars)     $ 10,832,073    
Preferred stock conversion into common stock, shares     266    
Description of warrants expiration   the Company issued to the placement agent in such offering warrants exercisable for 439 shares of Series 2 Convertible Preferred Stock at an initial exercise price of $1,250 per share, which expire seven years after the date of issuance.